| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Michael Berk | Q30504747 |
| Flávio Kapczinski | Q77015947 | ||
| P2093 | author name string | S. Dodd | |
| M. Bourin | |||
| T. Norman | |||
| G. S. Malhi | |||
| M. Kauer-Sant?Anna | |||
| P2860 | cites work | Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies | Q24672819 |
| Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression | Q28247703 | ||
| An open-label study of amisulpride in the treatment of mania | Q28250310 | ||
| Pramipexole for bipolar II depression: a placebo-controlled proof of concept study | Q28268655 | ||
| The neural basis of addiction: a pathology of motivation and choice | Q29615901 | ||
| Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence | Q29618819 | ||
| Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? | Q48118533 | ||
| Dopamine D2 receptors in depression measured with single photon emission computed tomography | Q48189545 | ||
| Clinical and psychometric correlates of dopamine D2 binding in depression | Q48582760 | ||
| Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes | Q48649203 | ||
| Dopamine agonist amineptine prevents the antidepressant effect of sleep deprivation. | Q48828124 | ||
| Dopaminergic sensitivity and prediction of antidepressant response. | Q51079476 | ||
| Haloperidol in Normals | Q51285137 | ||
| Perceived criticism from family members as a predictor of the one-year course of bipolar disorder. | Q51399319 | ||
| The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? | Q51951357 | ||
| Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy. | Q54525200 | ||
| Dopamine and depression: A review of recent evidence. I. Empirical studies | Q56814693 | ||
| A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission | Q57612892 | ||
| Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients | Q59792473 | ||
| Central Monoamine Deficiency in Depressions: Causative or Secondary Phenomenon?* | Q66887754 | ||
| A dopaminergic mechanism in mania | Q67824100 | ||
| Sulpiride treatment of acute mania with a comparison of the effects on plasma hormone concentrations of lithium and sulpiride treatment | Q69294866 | ||
| The spectrum of levodopa-related fluctuations in Parkinson's disease | Q72878531 | ||
| A history of substance abuse complicates remission from acute mania in bipolar disorder | Q73235144 | ||
| Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group | Q73370918 | ||
| Cognitive therapy for depression | Q77222112 | ||
| Magnetic resonance spectroscopic measurement of cerebral gamma-aminobutyric acid concentrations in patients with bipolar disorders | Q87485529 | ||
| Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. | Q31871442 | ||
| The role of dopamine in reward and pleasure behaviour--review of data from preclinical research | Q33214750 | ||
| Two novel variants in the DOPA decarboxylase gene: association with bipolar affective disorder. | Q33881980 | ||
| The role of dopamine in the mechanism of action of antidepressant drugs | Q34061085 | ||
| Dextroamphetamine-induced arousal in human subjects as a model for mania | Q34188627 | ||
| Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression | Q34275783 | ||
| Dopamine dysregulation syndrome in Parkinson's disease | Q34332717 | ||
| Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking | Q34367855 | ||
| Alcoholism: genes and mechanisms | Q34374370 | ||
| COMT polymorphisms and anxiety-related personality traits | Q34426642 | ||
| Association of the functional catechol-O-methyltransferase VAL158MET polymorphism with the personality trait of extraversion | Q34428387 | ||
| Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness | Q34518040 | ||
| Risk factors in relation to an emergence of bipolar disorder: a systematic review. | Q35190654 | ||
| Perspectives for the development of animal models of bipolar disorder | Q35642827 | ||
| Association study of catechol-O-methyltransferase gene and dopamine D4 receptor gene polymorphisms and personality traits in healthy young chinese females. | Q35855287 | ||
| Efficacy of atypical antipsychotics in bipolar disorder | Q35999567 | ||
| Attention-deficit/hyperactivity disorder pharmacogenomics | Q36159635 | ||
| Does dopamine dysfunction drive depression? | Q36728907 | ||
| Functional neuroimaging studies in mood disorders | Q38779398 | ||
| Signal transduction pathways. Molecular targets for lithium's actions | Q40437069 | ||
| The mesolimbic dopamine system as a target for rapid antidepressant action. | Q41623740 | ||
| A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits | Q42167773 | ||
| Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania | Q42679768 | ||
| Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study | Q43450848 | ||
| The prolactin response to sulpiride in major depression: the role of the D2 receptor in depression | Q43647934 | ||
| Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test? | Q43858325 | ||
| Increased successive negative contrast in rats withdrawn from an escalating-dose schedule of D-amphetamine | Q43867280 | ||
| Pramipexole for depression | Q43873936 | ||
| PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium | Q43977655 | ||
| PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania | Q44164492 | ||
| Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism | Q44327740 | ||
| Effects of a branched-chain amino acid drink in mania. | Q44336356 | ||
| Possible involvement of the dopamine D3 receptor locus in subtypes of bipolar affective disorder | Q44411376 | ||
| A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania | Q44684784 | ||
| Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania | Q45243903 | ||
| Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity | Q45778266 | ||
| Dopaminergic mechanism of antidepressant action in depressed patients | Q46429551 | ||
| Temperament and character in mood disorders: influence of DRD4, SERTPR, TPH and MAO-A polymorphisms | Q46828984 | ||
| Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers | Q46921505 | ||
| P433 | issue | s434 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| dopamine | Q170304 | ||
| Dopamine dysregulation syndrome | Q3508719 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 41-49 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Acta psychiatrica Scandinavica. Supplementum | Q26842026 |
| P1476 | title | Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder | |
| P478 | volume | 116 |
| Q28655245 | "Messing with the mind": evolutionary challenges to human brain augmentation |
| Q37242709 | 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder |
| Q26802127 | A Positive Affective Neuroendocrinology Approach to Reward and Behavioral Dysregulation |
| Q26786354 | A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates |
| Q34455901 | A highly tunable dopaminergic oscillator generates ultradian rhythms of behavioral arousal. |
| Q50261146 | A neuronal mechanism underlying decision-making deficits during hyperdopaminergic states |
| Q38194451 | A systems neuroscience perspective of schizophrenia and bipolar disorder |
| Q27023851 | Allostasis as a conceptual framework linking bipolar disorder and addiction |
| Q33560637 | Altered resting-state functional connectivity of striatal-thalamic circuit in bipolar disorder |
| Q47294091 | An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms |
| Q34657183 | Analysis of the presence or absence of atrophy of the subgenual and subcallosal cingulate cortices using voxel-based morphometry on MRI is useful to select prescriptions for patients with depressive symptoms |
| Q42702891 | Animal models for bipolar disorder: from bedside to the cage. |
| Q38899735 | Antidepressant-Induced Dopamine Receptor Dysregulation: A Valid Animal Model of Manic-Depressive Illness |
| Q39231042 | Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia |
| Q34078251 | Association study between a polymorphism at the 3'-untranslated region of CLOCK gene and attention deficit hyperactivity disorder |
| Q46118805 | Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population |
| Q45973903 | Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice. |
| Q34452274 | Better than I thought: positive evaluation bias in hypomania |
| Q34043769 | Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis |
| Q38995726 | Biological hypotheses and biomarkers of bipolar disorder |
| Q33435703 | Bipolar disorder and dopamine dysfunction: an indirect approach focusing on tardive movement syndromes in a naturalistic setting |
| Q47146263 | Bipolar disorder, a precursor of Parkinson's disease? |
| Q90746533 | Bipolar oscillations between positive and negative mood states in a computational model of Basal Ganglia |
| Q37384754 | Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial |
| Q33661489 | Can Antipsychotic Agents be Considered as Real Antimanic Treatments? |
| Q35049564 | Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor β-arrestin interactions |
| Q37590122 | Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain |
| Q35308508 | Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats |
| Q38751547 | Circadian clock gene aryl hydrocarbon receptor nuclear translocator-like polymorphisms are associated with seasonal affective disorder: An Indian family study |
| Q37142227 | Circadian polymorphisms associated with affective disorders. |
| Q53750293 | Cognitive manic symptoms associated with the P2RX7 gene in bipolar disorder. |
| Q38019745 | Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders |
| Q33976551 | Cross-species assessments of motor and exploratory behavior related to bipolar disorder |
| Q36546243 | Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder |
| Q35000942 | Dissociable brain structural changes associated with predisposition, resilience, and disease expression in bipolar disorder. |
| Q33691400 | Does the number of previous mood episodes moderate the relationship between alcohol use, smoking and mood in bipolar outpatients? |
| Q46709457 | Dopamine and bipolar disorder. |
| Q86422987 | Dopamine transporter gene may be associated with bipolar disorder and its personality traits |
| Q39159752 | Dopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis. |
| Q48129908 | Downregulation and upregulation of glial connexins may cause synaptic imbalances responsible for the pathophysiology of bipolar disorder |
| Q30367260 | Effects of Neonatal Dexamethasone Exposure on Adult Neuropsychiatric Traits in Rats. |
| Q48407594 | Effects of alpha-lipoic acid in an animal model of mania induced by D-amphetamine |
| Q92189332 | Effects of lithium on inflammatory and neurotrophic factors after an immune challenge in a lisdexamfetamine animal model of mania |
| Q33816563 | Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder |
| Q34439747 | Elevated reward-related neural activation as a unique biological marker of bipolar disorder: assessment and treatment implications. |
| Q42628955 | Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder |
| Q36766645 | Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward task |
| Q52691492 | Evaluation of Neurotransmitter Alterations in Four Distinct Brain Regions After Rapid Eye Movement Sleep Deprivation (REMSD) Induced Mania-Like Behaviour in Swiss Albino Mice. |
| Q43976588 | Evaluation of the antidepressant, anxiolytic and memory-improving efficacy of aripiprazole and fluoxetine in ethanol-treated rats |
| Q33811283 | Evidence for somatic gene conversion and deletion in bipolar disorder, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, type-1 diabetes, and type-2 diabetes |
| Q87922893 | Flipped Phenyl Ring Orientations of Dopamine Binding with Human and Drosophila Dopamine Transporters: Remarkable Role of Three Nonconserved Residues |
| Q34630380 | Functional and structural alterations in the cingulate motor area relate to decreased fronto-striatal coupling in major depressive disorder with psychomotor disturbances. |
| Q26782989 | Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder |
| Q47685038 | GBR 12909 administration as an animal model of bipolar mania: time course of behavioral, brain oxidative alterations and effect of mood stabilizing drugs. |
| Q36568973 | How assess drugs in the treatment of acute bipolar mania? |
| Q35742545 | Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans |
| Q50605503 | Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats. |
| Q34080310 | Integrated neurobiology of bipolar disorder |
| Q35978132 | Interaction between COMT rs5993883 and second generation antipsychotics is linked to decreases in verbal cognition and cognitive control in bipolar disorder |
| Q64085330 | Intra-individual variability in animal models of bipolar disorder |
| Q28085253 | Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies |
| Q26782867 | Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology |
| Q43063737 | Lack of association between MAGEL2 and schizophrenia and mood disorders in the Japanese population |
| Q92877549 | Lithium treatment impacts nucleus accumbens shape in bipolar disorder |
| Q43276213 | Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD. |
| Q26852133 | Memantine: New prospective in bipolar disorder treatment |
| Q91665452 | Mitochondrial DNA content and oxidation in bipolar disorder and its role across brain regions |
| Q33526671 | Modeling complex genetic and environmental influences on comorbid bipolar disorder with tobacco use disorder. |
| Q57997615 | Modeling gene-environment interaction in longitudinal data: Risk for neuroticism due to interaction between maternal care and the Dopamine 4 Receptor gene (DRD4) |
| Q30359575 | Modeling mania in preclinical settings: A comprehensive review. |
| Q30447653 | Neural activations during auditory oddball processing discriminating schizophrenia and psychotic bipolar disorder. |
| Q88968268 | Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies |
| Q48137161 | Neuron-glia interaction as a possible pathophysiological mechanism of bipolar disorder |
| Q38119411 | Novel nutritional treatment for manic and psychotic disorders: a review of tryptophan and tyrosine depletion studies and the potential of protein-based formulations using glycomacropeptide |
| Q37256691 | Olanzapine/fluoxetine combination for treatment-resistant depression: efficacy and clinical utility |
| Q93195661 | On the diagnostic and neurobiological origins of bipolar disorder |
| Q22252260 | Overlapping prefrontal systems involved in cognitive and emotional processing in euthymic bipolar disorder and following sleep deprivation: a review of functional neuroimaging studies |
| Q33817921 | Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia |
| Q26738789 | Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches |
| Q34551182 | Pathway analysis using information from allele-specific gene methylation in genome-wide association studies for bipolar disorder |
| Q82078137 | Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study |
| Q34325612 | Potential mechanisms of action of lithium in bipolar disorder. Current understanding |
| Q58729467 | Protein Kinase C Activity and Delayed Recovery of Sleep-Wake Cycle in Mouse Model of Bipolar Disorder |
| Q38753308 | Reward processing and mood-related symptoms: An RDoC and translational neuroscience perspective |
| Q90689657 | Risk of Developing Parkinson Disease in Bipolar Disorder: A Systematic Review and Meta-analysis |
| Q48029404 | Sensitivity to positive and negative feedback in euthymic patients with bipolar I disorder: the last episode makes the difference. |
| Q34195351 | Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms |
| Q34357384 | Sodium butyrate reverses the inhibition of Krebs cycle enzymes induced by amphetamine in the rat brain. |
| Q44522561 | Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder |
| Q47990255 | Stressful life events and catechol-O-methyl-transferase (COMT) gene in bipolar disorder |
| Q37794043 | Switching to Hypomania and Mania: Differential Neurochemical, Neuropsychological, and Pharmacologic Triggers and Their Mechanisms |
| Q38322773 | The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases. |
| Q26862278 | The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder |
| Q36350054 | The Relationship between Serum Vitamin D Level and Attention Deficit Hyperactivity Disorder |
| Q64098164 | The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia |
| Q47713553 | The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder. |
| Q35054681 | The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited |
| Q36132270 | The clinical significance of creativity in bipolar disorder |
| Q28083109 | The development and course of bipolar spectrum disorders: an integrated reward and circadian rhythm dysregulation model |
| Q33593061 | The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment |
| Q38189780 | The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment |
| Q38797294 | The known and missing links between Toxoplasma gondii and schizophrenia. |
| Q38085460 | The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment |
| Q38031289 | The relationship between oxidative stress and post-translational modification of the dopamine transporter in bipolar disorder |
| Q50629712 | The role of encoding strategies in contextual memory deficits in patients with bipolar disorder. |
| Q37385678 | The role of estrogen in the treatment of men with schizophrenia |
| Q38025454 | The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence |
| Q38004234 | The role of parasites and pathogens in influencing generalised anxiety and predation-related fear in the mammalian central nervous system. |
| Q22306157 | Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour? |
| Q36605607 | Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature |
| Q102379433 | Valproate reverses mania-like behaviors in mice via preferential targeting of HDAC2 |
| Q35236225 | Valuing happiness is associated with bipolar disorder |
| Q35302795 | Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis. |
| Q37026256 | When the party is over: depressive-like states in rats following termination of cortical D1 receptor overexpression |
Search more.